Skip to content
Clinical Trial Events
SCOPE Summit for Clinical Ops Executives

Panel Digital Health Technologies track

Building the Business Case for Adopting Digital Endpoints in Clinical Trials

Tue, Feb 4, 2025 · 4:50–5:25 PM EST Rosen Shingle Creek

About this session

Panel Discussion.

FDA recently qualified the first digital endpoint for clinical trials, and recent research has shown that digital endpoints can reduce the timelines and cost of clinical trials. However, to date, decision-makers have not had the clear value assessments, routine use cases, and efficient deployment strategies needed to confidently deploy digital endpoints at scale. In this session, collaborators from the Digital Medicine Society (DiMe)'s Building the Business Case for Digital Endpoints team will unveil new insights and project resources designed to shed light on the full return on investment of digital endpoints and to drive adoption in high-quality, fit-for-purpose digital measures as endpoints in clinical research. Discussion points:Learn about DiMe’s value framework for including digital endpoints in clinical research, including when and how digital endpoints can show true value during medicinal product developmentUnderstand how to measure and evaluate the return on investment generated by digital endpointsCultivate expertise towards making informed decisions and sustain investment in integrating digital endpoints into successful digital health strategies

Speakers